5GVQ

Solution structure of the first RRM domain of human spliceosomal protein SF3b49

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	0.8 mM [U-100% 13C; U-100% 15N] human spliceosomal protein SF3b49	90% H2O/10% D2O	100 mM	7.0	1 atm	298	Bruker AVANCE 800
2	3D 1H-13C NOESY	0.8 mM [U-100% 13C; U-100% 15N] human spliceosomal protein SF3b49	90% H2O/10% D2O	100 mM	7.0	1 atm	298	Bruker AVANCE 800
3	2D 1H-15N HSQC	0.8 mM [U-100% 13C; U-100% 15N] human spliceosomal protein SF3b49	90% H2O/10% D2O	100 mM	7.0	1 atm	298	Bruker AVANCE 800
4	2D 1H-13C HSQC	0.8 mM [U-100% 13C; U-100% 15N] human spliceosomal protein SF3b49	90% H2O/10% D2O	100 mM	7.0	1 atm	298	Bruker AVANCE 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	data analysis	KUJIRA		Kobayashi N
4	data analysis	NMRView		Johnson, One Moon Scientific
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.